RHINISENG® and ERYSENG® PARVO arrive in South Korea

Swine

The innovative RHINISENG® and ERYSENG® PARVO vaccines are now available in South Korea. This was announced at the event that HIPRA organized at the end of April in Daejeon city (South Korea).

seng-range-korea-swine

The Business Manager of the subsidiary, Myung-hyee Kim, was in charge of welcoming the act in which RHINISENG® was presented, the only registered vaccine against Progressive and Non-Progressive Atrophic Rhinitis and ERYSENG® PARVO, the new vaccine for the prevention of reproductive problems associated with Swine Erysipelas and Porcine Parvovirus.

In addition, the new concept of the TRUE FUSION was introduced, a unique combination between ERYSENG® PARVO and UNISTRAIN® PRRS

seng-range-korea-swine-S2

The event also featured two presentations by professors Young-soo Lyoo and Jeong-hee Han on the incidence and great impact that both atrophic rhinitis and reproductive diseases, respectively, cause in the Korean swine industry today.

seng-range-korea-swine

This launch materializes the arrival of two new products to Korea, ERYSENG® PARVO and RHINISENG® which, together with SUISENG®, complete the SENG RANGE as "the most modern and complete range of vaccines for breeders", reinforcing HIPRA's commitment to continue to be the reference in prevention.